Source: Annual Congress 2010 - COPD: symptoms and staging
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Gagnon, D. Saey, S. Provencher, J. Milot, F. Maltais (Canada). Impact of symptomatology in patients with GOLD stage I COPD. Eur Respir J 2010; 36: Suppl. 54, 5548

Member's Comments

No comment yet.

Related content which might interest you: Impact of comorbidities on survival of patients with COPD according to GOLD stages Source: Annual Congress 2011 - COPD: burden of disease, imaging and management Year: 2011 GOLD assessment of COPD patients: Impact of symptoms assessment choice Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012 High prevalence of osteoporosis in COPD patients independent of GOLD stage Source: Annual Congress 2010 - What's new in pulmonary rehabilitation and chronic care in 2010 Year: 2010 Effect of COPD severity on hemodynamic responses to exercise in patients with GOLD stages I-IV Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011 GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003 Anxiety and dyspnea relation in early stage COPD patients Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Rehabilitation programs in patients in different severity stage of COPD (GOLD II-to-IV): analysis of the results Source: Eur Respir J 2005; 26: Suppl. 49, 69s Year: 2005 Comorbidities in stage IV COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Validation of non-spirometric predictors of COPD to the GOLD stage classification Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 Copeptin and GOLD stage are independent predictors of exertional desaturation in patients with COPD Source: Annual Congress 2010 - Research development in exercise and gas exchange Year: 2010 Effects of tiotropium on lung volumes during exercise in GOLD stage II to IV COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 171s Year: 2006 COPD GOLD stage 1: Is it really a disease? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Prevalence and severity of GOLD defined COPD in adults Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002 The prevalence of QTc-prolongation increase by GOLD stage in COPD Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 The effect of changing GOLD severity stage on long-term mortality in COPD Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Quality of life, stage severity and COPD Source: Eur Respir J 2009; 33: 953-955 Year: 2009 Distribution of COPD patients in the GOLD assessment framework by exacerbations Source: Annual Congress 2012 - COPD epidemiology Year: 2012 COPD comorbidities and risk assessment according to GOLD 2011 revision Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013